Protective effect of resveratrol against neuronal damage through oxidative stress in cerebral hemisphere of aluminum and fluoride treated rats
- PMID: 28652849
- PMCID: PMC5458107
- DOI: 10.1515/intox-2016-0009
Protective effect of resveratrol against neuronal damage through oxidative stress in cerebral hemisphere of aluminum and fluoride treated rats
Abstract
Aluminum has no defined biological function and it is potentially involved in the pathogenesis of neurodegenerative disorders. Furthermore, the presence of fluoride causes more aluminum to accumulate in the brain, resulting in increased neuronal damage. In recent years, resveratrol through its ameliorative effects was found to be a neuroprotectant. This study reports the protective effects of resveratrol on combined aluminum and fluoride induced neuronal damage through oxidative stress in rats. Protective effects of resveratrol (30 mg/kg b.w) on markers of oxidative stress were determined in rats exposed to aluminum chloride (100 mg/kg b.w) along with sodium fluoride (10 mg/kg b.w) for 8 weeks. The results showed a statistically significant (p<0.05) increase in lipid peroxidation (LPx) as well as a significant (p<0.05) decrease in superoxide dismutase and catalase activity. Enlarged cells, neurofibrillary tangles, and vacuolar spaces showing oxidative stress in the cerebral cortex were also observed in hematoxylin and eosin stained sections in aluminum and fluoride treated rats. Administration of resveratrol along with aluminum + fluoride showed significant reversal of oxidative stress and neuronal damage in rats. Thus resveratrol potentially acts as a neuroprotectant against aluminum chloride + sodium fluoride induced neuronal damage through its anti-oxidant efficacy.
Keywords: aluminium; fluoride; neurodegeneration; oxidative stress; resveratrol.
Figures
References
-
- Anane R, Creppy EE. Lipid peroxidation as pathway of aluminium cytotoxicity in human skin fibroblast cultures: prevention by superoxide dismutase+catalase and vitamins E and C. Hum Exp Toxicol. 2001;20:477–481. - PubMed
-
- Armstrong RA, Winsper SJ, Blair JA. Aluminium and Alzheimer’s disease: review of possible pathogenic mechanisms. Dementia. 1996;7(1):1–9. - PubMed
-
- Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493–506. - PubMed
-
- Bimla Nehru, Priya Anand. Oxidative damage following chronic aluminium exposure in adult and pup rat brains. Journal of Trace Elements in Medicine and Biology. 2005;19:203–208. - PubMed
-
- Blaylock RL. Aluminium induced immunoexcitotoxicity in neurodevelopmental and neurodegenerative disorders. Current Inorganic Chemistry. 2012;2(1):1–8.
LinkOut - more resources
Full Text Sources
Other Literature Sources